Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Surv Ophthalmol. 2017 Dec 27;63(4):453–479. doi: 10.1016/j.survophthal.2017.12.008

Figure 7. Fate of high-risk minor H–disparate corneal transplants in BALB/c mice (n = 14/group) that received corneal grafts from B10.D2 mice and were randomized to receive anti-CD154 or hamster Ig. Graft rejection was scored clinically.

Figure 7

(A), and graft survival data are presented as Kaplan–Meier survival curves (B). Anti-CD154 therapy enhanced the survival of minor H–disparate grafts in high-risk transplantation (**P = 0.0001).155 (Adapted from Qain et al with permission from IOVS)